MedPath

Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer II

Not Applicable
Completed
Conditions
Colorectal Cancer
Colon Cancer
Rectal Cancer
Interventions
Behavioral: Fitbit and Text Messages
Registration Number
NCT03524716
Lead Sponsor
University of California, San Francisco
Brief Summary

There is a critical need for physical activity interventions in colorectal cancer (CRC). The investigators have developed a digital health physical activity intervention, Smart Pace, which includes a wearable tracker (Fitbit) and text messaging and aims to have patients build up to 150 min/wk of moderate activity. In this study, the investigators propose to expand and improve Smart Pace, including: 1) enrolling patients during chemotherapy; 2) tailoring text messages to individual preferences and treatment timing; and 3) adding resources to support home-based exercise. The study is a 12-week pilot randomized controlled trial (RCT) to evaluate the feasibility of this novel digital health physical activity intervention among 48 CRC patients on chemotherapy. The specific aims are to: 1) Determine the feasibility of the intervention via adherence and attrition, and determine the acceptability of the intervention via questionnaires and semi-structured interviews . 2) Estimate the effect of the intervention vs. usual care on physical activity, QOL, and symptoms at 12-weeks . And 3) Explore the impact of the intervention vs. usual care on fitness, weight, waist circumference, and blood pressure at 12-weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Diagnosed with colon or rectal adenocarcinoma
  • Expected to receive at least 12 weeks of chemotherapy
  • Able to speak and read English
  • Access to a mobile phone with Internet and text messaging capabilities
  • ≥4 weeks since last major surgery and fully recovered
  • ≥18 years old
  • Physician consent to participate in unsupervised moderate intensity physical activity
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-1
Read More
Exclusion Criteria
  • Engaging in 150 minutes/week or more of moderate physical activity, 75 minutes/week or more of vigorous physical activity, or an equivalent combination
  • Hypertension that is not well-controlled (≥160/90) on anti-hypertensive therapy
  • Any contraindications to exercise, including, but not limited to: brain metastases; current congestive heart failure (New York Heart Association Class II, III or IV); serious or nonhealing wound, ulcer, or bone fracture; spinal cord compromise or instrumentation due to metastatic disease; peripheral neuropathy ≥grade 3; advanced Chronic Obstructive Pulmonary Disease (COPD) on oxygen
  • Serious cardiovascular event within 6 months including, but not limited to, transient ischemic attack (TIA), cerebrovascular accident (CVA), or myocardial infarction (MI)
  • Has been told by a doctor that he/she has a heart condition and recommended to only engage in medically supervised activity
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fitbit and Text MessagesFitbit and Text MessagesParticipants randomized to this arm receive print materials and a Fitbit Flex 2 at baseline and daily text messages for 12 weeks.
Primary Outcome Measures
NameTimeMethod
Fitbit wear timeup to 12 weeks from study start

Number of study days Fitbit is worn

Acceptability of the interventionAt 12 weeks from study start

Acceptability will be assessed with an investigator created questionnaire among participants in the intervention arm.

Text message response rateup to 12 weeks from study start
Secondary Outcome Measures
NameTimeMethod
Objective physical activityAt 0 weeks and 12 weeks from study start

Minutes of moderate-to-vigorous physical activity per week measured by accelerometer

FatigueAt 0 and 12 weeks from study start

Lee Fatigue Scale

Cardiorespiratory fitnessAt 0 and 12 weeks from study start

6 minute walk test

Anthropometrics, Waist circumferenceAt 0 and 12 weeks from study start
Anthropometrics, Body weightAt 0 and 12 weeks from study start
Sleep qualityAt 0 and 12 weeks from study start

Will be assessed by the Pittsburgh Sleep Quality Index, providing a score ranging from 0 to 21, where lower scores denote a healthier sleep quality.

Health-related quality of life in cancer patientsAt 0 and 12 weeks from study start

Will be assessed via the European Organization for Research and Treatment (EORTC) of Cancer Quality of Life Questionnaire-Core 30

Health-related quality of life in colorectal cancer patientsAt 0 and 12 weeks from study start

Will be assessed via the European Organization for Research and Treatment (EORTC) of Cancer Quality of Life Questionnaire-Core 29

NeuropathyAt 0 and 12 weeks from study start

Will be assessed by the Chemotherapy-Induced Peripheral Neuropathy 20 (CIPN20) questionnaire, a 20-item quality of life questionnaire.

AnxietyAt 0 and 12 weeks from study start

Will be assessed by the Spielberger State-Trait Anxiety Inventories (STAI), consisting of 40 questions on a self-report basis. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

DepressionAt 0 and 12 weeks from study start

Will be assessed by the Center for Epidemiological Studies-Depression Scale (CES-D), a brief self-report questionnaire which consists of 20 questions. Scores on the CES-D range from 0 to 60, in which higher scores suggest a greater presence of depressive symptoms.

Leisure-time physical activityAt 0 and 12 weeks from study start

Will be assessed via the Harvard Health Professionals Follow-up Study (HPFS) physical activity questionnaire.

Perceived barriers to physical activityAt 0 and 12 weeks from study start

Modified from the Project Graduate Ready for Activity Daily(GRAD) survey - 24 items plus a write-in option.

Exercise ConfidenceAt 0 and 12 weeks from study start

Modified from the Project GRAD (Graduate Ready for Activity Daily) survey - 11 items.

Social supportAt 0 and 12 weeks from study start

Modified from the Project GRAD (Graduate Ready for Activity Daily) survey - 13 items asked about social support.

Trial Locations

Locations (1)

University of California, San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath